Patent · US Active

(1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-uanidino-2-hydroxyl-cyclopentyl-1-carboxylic acid hydrates pharmaceutical uses thereof

US9518008B2 · kind B2 · utility

1Cited by

1References

17Claims

0Family size

Assignee

INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES · CN

Inventors

Song Li · Beijing, CN
Wu Zhong · Beijing, CN
Zhibing Zheng · Beijing, CN
Xinbo Zhou · Beijing, CN
Junhai Xiao · Beijing, CN
Yunde Xie · Beijing, CN
Lili Wang · Beijing, CN
Xingzhou Li · Beijing, CN
Guoming Zhao · Beijing, CN
Xiaokui Wang · Beijing, CN
Hongying Liu · Beijing, CN

Key dates

Filing date	Oct 10, 2014
Grant date	Dec 13, 2016
Priority date	—
Expiry date	Oct 10, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to (1S,2S,3S,4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentyl-1-carboxylic acid hydrates compounds, preparing methods thereof, pharmaceutical compositions containing said compounds and preparing methods thereof, and the clinical uses of said compounds as neuramidinase inhibitors for anti-influenza.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.